FDA Inspection 970690 — Azurity Pharmaceuticals, Inc.
The FDA completed an inspection of Azurity Pharmaceuticals, Inc. on Apr 19, 2016 in Woburn, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 19, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Woburn, MA (United States)